Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254811 | 0.98 | CASP2 (0.51) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5547349 | 0.98 | CASP2 (0.51) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18118429 | 0.98 | CASP2 (0.51) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL23824100 | 0.98 | CASP2 (0.51) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22600490 | 0.95 | ALDH1A1 (0.50) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13032706 | 0.95 | ALDH1A1 (0.50) | ALDH1A1CASP2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL29300501 | 0.94 | CASP2 (0.51) | ALDH1A1CASP2MEN1KMT2ANAAA | |
| SCHEMBL29300509 | 0.91 | CASP2 (0.45) | ALDH1A1CASP2MEN1KMT2ANAAA | |
| SCHEMBL18623944 | 0.89 | SIGMAR1 (0.54) | ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL24410021 | 0.89 | MEN1 (0.46) | ALDH1A1MEN1KMT2ASMN1; SMN2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164775-A1 | RADIOLABELED COMPOUNDS TARGETNG THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023097038-A1 | CLEAVABLE RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | FULL-LIFE TECHNOLOGIES U.S. INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |